CAS 7380-40-7
:Bergamottine
- 4-[[(2E)-3,7-Dimethyl-2,6-octadien-1-yl]oxy]-7H-furo[3,2-g][1]benzopyran-7-one
- 4-{[(2E)-3,7-dimethylocta-2,6-dien-1-yl]oxy}-7H-furo[3,2-g]chromen-7-one
- 5-Geranoxypsoralen
- 7H-Furo[3,2-g][1]benzopyran-7-one, 4-[(3,7-dimethyl-2,6-octadienyl)oxy]-, (E)-
- 7H-Furo[3,2-g][1]benzopyran-7-one, 4-[[(2E)-3,7-dimethyl-2,6-octadien-1-yl]oxy]-
- 7H-Furo[3,2-g][1]benzopyran-7-one, 4-[[(2E)-3,7-dimethyl-2,6-octadienyl]oxy]-
- Bergamotine
- Bergaptin
- Bergamottin
Bergamottin
CAS :Bergamottin analytical standard provided with w/w absolute assay, to be used for quantitative titration.Formule :C21H22O4Degré de pureté :(HPLC) ≥99%Couleur et forme :PowderMasse moléculaire :338.41Bergamottin
CAS :Formule :C21H22O4Degré de pureté :97%Couleur et forme :SolidMasse moléculaire :338.3970Bergamottin
CAS :Formule :C21H22O4Degré de pureté :≥ 98.0%Couleur et forme :White to off-white powderMasse moléculaire :338.40Bergamottin
CAS :1.Formule :C21H22O4Degré de pureté :97.59% - 99.99%Couleur et forme :SolidMasse moléculaire :338.40Bergamottin
CAS :LactoneFormule :C21H22O4Degré de pureté :≥ 95.0 % (HPLC)Couleur et forme :PowderMasse moléculaire :338.4Bergamottin
CAS :Applications Bergamottin (BG), a component of grapefruit juice, is a mechanism-based inactivator of CYP3A4 and contributes, in part, to the grapefruit juice-drug interaction.
References Bailey, D., et al.: Clin. Pharmacol. Ther., 68, 468 (2000), Guo, L., et al.; Drug Metab. Dispos., 28, 766 (2000), Baer, B., et al.: Chem. Res. Toxicol., 20, 954 (2007), Lin, H., et al.: Drug Metab. Dispos., 39, 24 (2011);Formule :C21H22O4Couleur et forme :NeatMasse moléculaire :338.4Bergamottin
CAS :Bergamottin is a furanocoumarin compound, which is primarily found in grapefruit juice and other citrus fruits. It is derived from natural sources, specifically within the fruit and peel of grapefruits. The mode of action of Bergamottin involves the inhibition of the cytochrome P450 enzymes, particularly CYP3A4, which play a significant role in the metabolism of various drugs. This inhibitory effect can alter the pharmacokinetics of certain medications by increasing their bioavailability.
Formule :C21H22O4Degré de pureté :Min. 98 Area-%Couleur et forme :White PowderMasse moléculaire :338.4 g/mol








